- Home
- OMI vs SEPN Comparison
OMI vs SEPN Comparison
Compare OMI & SEPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMI
- SEPN
- Stock Information
- Founded
- OMI 1882
- SEPN 2022
- Country
- OMI United States
- SEPN United States
- Employees
- OMI N/A
- SEPN N/A
- Industry
- OMI Medical Specialities
- SEPN
- Sector
- OMI Health Care
- SEPN
- Exchange
- OMI Nasdaq
- SEPN NYSE
- Market Cap
- OMI 545.4M
- SEPN 453.2M
- IPO Year
- OMI N/A
- SEPN 2024
- Fundamental
- Price
- OMI $7.98
- SEPN $11.97
- Analyst Decision
- OMI Hold
- SEPN Strong Buy
- Analyst Count
- OMI 6
- SEPN 5
- Target Price
- OMI $12.67
- SEPN $26.75
- AVG Volume (30 Days)
- OMI 1.4M
- SEPN 437.4K
- Earning Date
- OMI 08-01-2025
- SEPN 08-15-2025
- Dividend Yield
- OMI N/A
- SEPN N/A
- EPS Growth
- OMI N/A
- SEPN N/A
- EPS
- OMI N/A
- SEPN N/A
- Revenue
- OMI $10,720,251,000.00
- SEPN $977,000.00
- Revenue This Year
- OMI $3.66
- SEPN $3,429.67
- Revenue Next Year
- OMI $2.52
- SEPN N/A
- P/E Ratio
- OMI N/A
- SEPN N/A
- Revenue Growth
- OMI 2.84
- SEPN 108.76
- 52 Week Low
- OMI $6.07
- SEPN $4.17
- 52 Week High
- OMI $16.98
- SEPN $28.99
- Technical
- Relative Strength Index (RSI)
- OMI 47.34
- SEPN N/A
- Support Level
- OMI $7.03
- SEPN N/A
- Resistance Level
- OMI $9.08
- SEPN N/A
- Average True Range (ATR)
- OMI 0.51
- SEPN 0.00
- MACD
- OMI -0.10
- SEPN 0.00
- Stochastic Oscillator
- OMI 32.40
- SEPN 0.00
About OMI Owens & Minor Inc.
Owens & Minor Inc distributes consumable medical supplies to a variety of providers. The business is under two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment manufactures and sources medical surgical products through its production and kitting operations and provides medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies. Majority of the revenue is generated from Products & Healthcare Services segment.
About SEPN SEPTERNA INC
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.